2022 Pharmacy Conditions of Participation

Tuesday, December 06, 2022 11:00 AM - 12:00 PM   iCalendar

Join NCHA for a webinar, "Pharmacy Conditions of Participation" on Tuesday, Dec. 6, 2022 from 11 am to 12 pm. This webinar will provide information about the recent changes in Medicare’s conditions of participation, which require hospitals to establish a formalized antibiotic stewardship program. This program also reviews the existing conditions of participation and problematic pharmacy standards.

The Centers for Medicare and Medicaid Services' interpretive guidelines address medication management and pharmacy-related standards. Hospitals can look to these standards when CMS conducts a survey. Medication management also is a focus for The Joint Commission. Medication errors account for the largest number of medical errors in health care. They are also the most- common reason for unnecessary hospital readmissions. For the first time, CMS mentions that nursing needs to be aware of the pharmacy standards. This includes medication errors, adverse events, drug incompatibilities, self‐administered medication and required medication policies.


  • Describe CMS requirements for pharmaceutical services.
  • Describe minimum security requirements.
  • Explain basic required policies and procedure.
  • Explain patient safety measures for medications.
  • Discuss the role of the interprofessional team in compliance with the Pharmacy Conditions of Participation.

Pharmacists, Physicians, Compliance Officers, Risk Managers, Patient Safety Director, Performance Improvement Director and Nurse Leaders.

Select your registration option and receive a link to share with your hospital or facility staff.
$185 NCHA Member Facilities

  • Instructions
    Register your group for the webinar and share the zoom registration link. Those individuals interested in viewing the recording must register separately in Zoom prior to the start of the webinar. Zoom will send an email containing an access code to view the recording. CE's are included for all participants who participate in the LIVE webinar. All participants must attend LIVE to be eligible for credit. Instructions to obtain credit will be shared after the webinar.


Nancy Ruzicka, JM, MBA, BS, is a consultant on state and federal rules, regulations and interpretative guidelines. Ruzicka previously worked as director of integrity and compliance and privacy official at MercyOne Des Moines and director of regulatory compliance at UnityPoint Health-Des Moines. She also has more than 20 years of experience with the Iowa Department of Inspections and Appeals. Ruzicka holds master’s degrees in health law and business administration and a bachelor’s degree in pharmacy, all from Drake University. She is certified in health care compliance and maintains her Iowa pharmacy license.


Map & Directions

Accreditation Statement
 In support of improving patient care, this activity has been planned and implemented by AXIS Medical Education and North Carolina Healthcare Association. AXIS Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. This activity was planned by and for the healthcare team, and learners will receive 2.0 interprofessional Continuing Education (IPCE) credit for learning and change.

Credit Designation for Pharmacists
This knowledge-based activity is approved for a maximum of 2.0 contact hours of continuing pharmacy education credit.
Credit Designation for Nursing
AXIS Medical Education designates this continuing nursing education activity for 2.0 contact hours.
Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

AXIS Contact Information 
For information about the accreditation of this program please contact AXIS at info@axismeded.org.

Disclosure of Conflicts of Interest 
AXIS Medical Education requires faculty, instructors, authors, planners, directors, managers, reviewers and other individuals who are in a position to control the content of this activity to disclose all real or apparent conflicts of interest they may have with ineligible companies. An ineligible entity is any organization whose primary business is t producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflicts of interest are identified and mitigated prior to initiation of the planning phase for an activity.  

AXIS has mitigated and disclosed to learners all relevant conflicts of interest disclosed by  staff, planners, faculty/authors, peer reviewers, or others in control of content for this activity. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation or activity. Disclosure information for faculty, authors, course directors, planners, peer reviewers, and/or relevant staff is provided with this activity. 

The faculty, Nancy Ruzicka, JM, MBA, BS, reported no relevant financial relationships or relationships she has with ineligible companies of any amount during the past 24 months. 

The directors, planners, managers and reviewers reported the following financial relationships they have with any ineligible company of any amount during the past 24 months: 

Name of Planner/Manager    Reported Financial Relationship
James Hayes, PMP - Nothing to Disclose
Holly M. Hampe, D.Sc., RN, MHA, MRM - Nothing to Disclose
Dee Morgillo, MEd., MT (ASCP), CHCP - Nothing to Disclose

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Requirements for credit:  

  • Attend/participate in the educational activity and review all course materials. 
  • Complete the CE Declaration form online by 11:59 pm ET December 31, 2022. Instructions will be provided at the conclusion of each Webinar.  If you do not enter the online portal by the above date, you will not be able to retrieve your statement of participation. 
  • Upon successful completion of the online form, your statement of completion will be presented to you to print. Pharmacists, your record will be automatically uploaded to CPE Monitor.